Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease

NCT00833690 is registered in ClinicalTrials.gov with The Parkinson Study Group as lead sponsor.

NCT NCT00833690
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00833690 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Lead sponsor
The Parkinson Study Group
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2009
Completion date
December 31, 2012
Enrollment
75 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease